About Ankara University School of Medicine
Ankara University Medical School is a medical school located in the Sıhhiye district of Ankara, Turkey. It opened in 1945 as the second medical school in Turkey, when Istanbul Medical School could no longer keep up with the demand for trained doctors.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Ankara University
6
Boehringer Ingelheim
3
Nanfang Hospital of Southern Medical University
3
Abbott Nutrition
1
Actelion
1
Amgen
1
Arbeitsgemeinschaft medikamentoese Tumortherapie
1
Ascendis Pharma A/S
1
Celgene
1
Cidara Therapeutics Inc.
1
Daiichi Sankyo Turkey, a Daiichi Sankyo Company
1
Clinical Trials at Ankara University School of Medicine
During the past decade, Ankara University School of Medicine conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
2009-05-01
2011-08-01
Completed
178
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B
2011-04-01
2015-07-01
Completed
751
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
2012-06-06
2021-02-01
Completed
752
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
2013-01-07
2022-05-13
Completed
559
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
2013-07-01
2015-09-01
Completed
53
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ankara University School of Medicine" #1 sponsor was "Ankara University" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "Nanfang Hospital of Southern Medical University" with 3 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Actelion"
with 1 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara University School of Medicine"
#1 collaborator was "Ankara University" with 4 trials as a collaborator, "LanZhou University" with 4 trials as a collaborator, "Xingtai People's Hospital" with 4 trials as a collaborator, "Shandong Provincial Hospital" with 3 trials as a collaborator and "Southern Medical University, China" with 3 trials as a collaborator. Other collaborators include 45 different institutions and companies that were
collaborators in the rest 53 trials.
Clinical Trials Conditions at Ankara University School of Medicine
According to Clinical.Site data, the most researched conditions in "Ankara University School of Medicine" are
"Idiopathic Pulmonary Fibrosis" (3 trials), "Acute Pain" (1 trials), "Anemia of Prematurity" (1 trials), "Anesthesia, Spinal" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Ankara University School of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Ankara University School of Medicine
Most popular intervention types in "Ankara University School of Medicine" are "Drug" (18 trials), "Other" (5 trials), "Diagnostic Test" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Dexamethasone" (2 trials), "Nintedanib" (2 trials), "ACP-001" (1 trials) and "ACT-064992 (macitentan)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ankara University School of Medicine
The vast majority of trials in "Ankara University School of Medicine" are
29 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Ankara University School of Medicine
Currently, there are NaN active trials in "Ankara University School of Medicine".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Ankara University School of Medicine,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Ankara University School of Medicine, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 3 trials that are defined as “Not Applicable".